ScheBo Biotech

• Tel: 01256-477259
• Contact this Company »
• Visit Web Site »

Subscribe

ScheBo Biotech UK Limited belongs to Schebo Biotech AG. The rapidly growing high-tech parent company is dedicated to the development, production and worldwide distribution of innovative tests for human and veterinary diagnostics, as well as food safety.

In medical diagnostics, ScheBo Biotech is well-known for the Pancreatic Elastase 1 Stool Test ('faecal elastase'), which is rapidly becoming recognised as the "gold standard" of non-invasive pancreatic function tests. Recent guidelines produced by the British Society of Gastroenterology, and Association of Clinical Biochemist members, recommend this convenient, non-invasive, direct test of pancreatic exocrine function as "the test of first choice in patients who present with diarrhoea of putative pancreatic origin".

Highly specific monoclonal antibodies to human pancreatic elastase 1 enable quantitative determination using a single pea-sized stool sample, obviating lengthy urine or 72-hour stool collections. The development of the innovative Quick-Prep tubes has made sample preparation for the test considerably faster and more pleasant.

The ScheBo M2-PK Test is an innovative tumour marker, that measures the dimeric isoform of pyruvate kinase. The ScheBo Tumor M2-PK EDTA-Plasma Test assists monitoring the efficacy of therapy, patient follow-up and diagnosis in a wide range of different cancers, including gastrointestinal, breast, lung and urological tumours. New and encouraging results from clinical studies with the non-invasive ScheBo Tumor M2-PK Stool Test, which is independent of occult blood, show high sensitivity combined with high specificity in colorectal cancer screening.

Further information on these tests, and on the Brainostic test in food safety and Canine Pancreatic Elastase test can be found on the company website.

For further information, please contact:

Ivor Smith
ScheBo Biotech UK Limited
P.O. Box 6359,
Basingstoke,
RG22 4WE,
U.K.

Tel: 01256-477259
Fax: 01256-477259

Website: www.schebo.co.uk

Acute Pancreatitis

• Faster Pancreatic Serum Test Devised by Schebo Biotech »
  
  Ivor Smith
  ScheBo Biotech, a global leader in the provision of unique diagnostic tests, has made some significant improvements to its Pancreatic Elastase 1 Serum Test for acute pancreatitis.
  
  

An Alternative To Pancreolauryl

• Faecal Pancreatic Elastase Test: A Superior Alternative for Pancreolauryl Users »
  
  Phil Allcock
  Change is inevitable - but is invariably for the better. October 2005 saw a key change in the tests available for measuring pancreatic exocrine function, with the withdrawal of the Pancreolauryl Test (PLT) by Pfizer Consumer Healthcare.
  
  

Cancer/Diagnostic Tests

• Tumor M2 Pyruvate Kinase (Tumor M2-PK) »
  
  Phil Allcock
  A Tumour Metabolic marker for Gastrointestinal and other Cancers
  
  

Pancreatic Disease

• Faster and easier Schebo Biotech 'Faecal Elastase Test' »
  
  Ivor Smith
  The Pancreatic Elastase 1 Stool Test (commonly known as the Faecal Elastase Test) from ScheBo Biotech has recently been further enhanced. The revised test is much shorter to conduct and is also easier to carry out than ever - without any loss of reliability or accuracy.
  
  

Cancer Research

• M2-PK Enzyme in Cancer Research »
  Pioneering findings in understanding cancer published in ‘Nature’: ‘M2-PK’ identified as a key enzyme in the diagnosis and therapy of cancer.
  
  

Coeliac Disease

• Coeliac disease and pancreatic exocrine insufficiency »
  Historically, after diagnosis and the introduction of a gluten free diet, coeliac disease patients who experienced ongoing gastrointestinal symptoms were frequently suspected of failing to comply with their dietary restrictions.